{"id":"W4220907252","doi":"10.1136/bmj-2021-069761","title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","year":2022,"lang":"en","type":"article","venue":"BMJ","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":681,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Agency for Toxic Substances and Disease Registry; National Institute of Allergy and Infectious Diseases; Centers for Disease Control and Prevention; Regeneron Pharmaceuticals; National Institutes of Health; Pfizer; Incyte; York University; Vanderbilt University Medical Center; University of Oxford; Vanderbilt University; Intermountain Research and Medical Foundation; Marcus Foundation; Cincinnati Children's Hospital Medical Center; National Institute of General Medical Sciences; United Therapeutics Corporation; Medpace; Brigham Young University; Gilead Sciences; Agency for Healthcare Research and Quality; Sanofi; U.S. Department of Defense; Abbott Laboratories; National Heart, Lung, and Blood Institute","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Odds ratio; Confidence interval; Observational study; Internal medicine; 2019-20 coronavirus outbreak; Virology; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1417907778579062,"score_gpt":0.4458875981418364,"score_spread":0.3040968202839302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}